Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: Clinical and economic impact
European Journal of Cancer · 2026-10 · 117789
DOI: 10.1016/j.ejca.2026.117789 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-10. Verfasst von Rebecca Schou Jurlander und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Cancer Immunotherapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Cancer Immunotherapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark.
- Department of Oncology, Odense University Hospital, Denmark.
- Department of Oncology, Aarhus University Hospital, Denmark.
- Department of Oncology, Aalborg University Hospital, Denmark.
- National Center for Cancer Immunotherapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Denmark. Electronic address: inge.marie.svane@regionh.dk.
Zitieren
APA
Jurlander, R. S., Borch, T. H., Petersen, S. K., Donia, M., Guldbrandt, L., Friis, R., Luczak, A. A., Schmidt, H., Ruhlmann, C., Bastholt, L., Ellebaek, E., & Svane, I. M. (2026). Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: Clinical and economic impact. European Journal of Cancer, 117789. https://doi.org/10.1016/j.ejca.2026.117789
Vancouver
Jurlander RS, Borch TH, Petersen SK, Donia M, Guldbrandt L, Friis R, et al. Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: Clinical and economic impact. European Journal of Cancer. 2026:117789. doi:10.1016/j.ejca.2026.117789
BibTeX
@article{Jurlander2026,
author = {Jurlander, Rebecca Schou and Borch, Troels Holz and Petersen, Søren Kjær and Donia, Marco and Guldbrandt, Louise and Friis, Rasmus and Luczak, Adam Andrzej and Schmidt, Henrik and Ruhlmann, Christina and Bastholt, Lars and Ellebaek, Eva and Svane, Inge Marie},
title = {Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: Clinical and economic impact},
journal = {European Journal of Cancer},
year = {2026},
pages = {117789},
doi = {10.1016/j.ejca.2026.117789}
}
EUVIMED